Having found that genes in Cluster 2 were associated with estrogen signaling, and that CpGs in Cluster 2 were located in binding regions of ERα, FOXA1, and GATA3, we further investigated the level of DNA methylation of these CpGs in regard to histopathological features and molecular classification of breast cancer patients. This evidence concerns the gene FOXA1 and breast carcinoma.